The global market for Intravenous (IV) Ibuprofen was valued at US$ 8927 million in the year 2024 and is projected to reach a revised size of US$ 18700 million by 2031, growing at a CAGR of 11.3% during the forecast period.

Intravenous (IV) Ibuprofen Market

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.

North American market for Intravenous (IV) Ibuprofen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravenous (IV) Ibuprofen is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Intravenous (IV) Ibuprofen include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals, Al Nabeel International, Laboratorios Valmorca, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Ibuprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Ibuprofen.

The Intravenous (IV) Ibuprofen market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous (IV) Ibuprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous (IV) Ibuprofen manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Intravenous (IV) Ibuprofen Market Report

Report Metric	Details
Report Name	Intravenous (IV) Ibuprofen Market
Accounted market size in year	US$ 8927 million
Forecasted market size in 2031	US$ 18700 million
CAGR	11.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	100 mg Dose 200 mg Dose 400 mg Dose 800 mg Dose
Segment by Application	Pain Fever Inflammation
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals, Al Nabeel International, Laboratorios Valmorca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravenous (IV) Ibuprofen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravenous (IV) Ibuprofen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Intravenous (IV) Ibuprofen Market growing?

Ans: The Intravenous (IV) Ibuprofen Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the Intravenous (IV) Ibuprofen Market size in 2031?

Ans: The Intravenous (IV) Ibuprofen Market size in 2031 will be US$ 18700 million.

Who are the main players in the Intravenous (IV) Ibuprofen Market report?

Ans: The main players in the Intravenous (IV) Ibuprofen Market are Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals, Al Nabeel International, Laboratorios Valmorca

What are the Application segmentation covered in the Intravenous (IV) Ibuprofen Market report?

Ans: The Applications covered in the Intravenous (IV) Ibuprofen Market report are Pain, Fever, Inflammation

What are the Type segmentation covered in the Intravenous (IV) Ibuprofen Market report?

Ans: The Types covered in the Intravenous (IV) Ibuprofen Market report are 100 mg Dose, 200 mg Dose, 400 mg Dose, 800 mg Dose

1 Intravenous (IV) Ibuprofen Market Overview

1.1 Product Definition

1.2 Intravenous (IV) Ibuprofen by Type

1.2.1 Global Intravenous (IV) Ibuprofen Market Value Comparison by Type (2024 VS 2031)

1.2.2 100 mg Dose

1.2.3 200 mg Dose

1.2.4 400 mg Dose

1.2.5 800 mg Dose

1.3 Intravenous (IV) Ibuprofen by Application

1.3.1 Global Intravenous (IV) Ibuprofen Market Value by Application (2024 VS 2031)

1.3.2 Pain

1.3.3 Fever

1.3.4 Inflammation

1.4 Global Intravenous (IV) Ibuprofen Market Size Estimates and Forecasts

1.4.1 Global Intravenous (IV) Ibuprofen Revenue 2020-2031

1.4.2 Global Intravenous (IV) Ibuprofen Sales 2020-2031

1.4.3 Global Intravenous (IV) Ibuprofen Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Intravenous (IV) Ibuprofen Market Competition by Manufacturers

2.1 Global Intravenous (IV) Ibuprofen Sales Market Share by Manufacturers (2020-2025)

2.2 Global Intravenous (IV) Ibuprofen Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Intravenous (IV) Ibuprofen Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Intravenous (IV) Ibuprofen, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Intravenous (IV) Ibuprofen, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Intravenous (IV) Ibuprofen, Product Type & Application

2.7 Global Key Manufacturers of Intravenous (IV) Ibuprofen, Date of Enter into This Industry

2.8 Global Intravenous (IV) Ibuprofen Market Competitive Situation and Trends

2.8.1 Global Intravenous (IV) Ibuprofen Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Intravenous (IV) Ibuprofen Players Market Share by Revenue

2.8.3 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Intravenous (IV) Ibuprofen Market Scenario by Region

3.1 Global Intravenous (IV) Ibuprofen Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Intravenous (IV) Ibuprofen Sales by Region: 2020-2031

3.2.1 Global Intravenous (IV) Ibuprofen Sales by Region: 2020-2025

3.2.2 Global Intravenous (IV) Ibuprofen Sales by Region: 2026-2031

3.3 Global Intravenous (IV) Ibuprofen Revenue by Region: 2020-2031

3.3.1 Global Intravenous (IV) Ibuprofen Revenue by Region: 2020-2025

3.3.2 Global Intravenous (IV) Ibuprofen Revenue by Region: 2026-2031

3.4 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Country

3.4.1 North America Intravenous (IV) Ibuprofen Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Intravenous (IV) Ibuprofen Sales by Country (2020-2031)

3.4.3 North America Intravenous (IV) Ibuprofen Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Country

3.5.1 Europe Intravenous (IV) Ibuprofen Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Intravenous (IV) Ibuprofen Sales by Country (2020-2031)

3.5.3 Europe Intravenous (IV) Ibuprofen Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Region

3.6.1 Asia Pacific Intravenous (IV) Ibuprofen Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2020-2031)

3.6.3 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Intravenous (IV) Ibuprofen Market Facts & Figures by Country

3.7.1 Latin America Intravenous (IV) Ibuprofen Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Intravenous (IV) Ibuprofen Sales by Country (2020-2031)

3.7.3 Latin America Intravenous (IV) Ibuprofen Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Country

3.8.1 Middle East and Africa Intravenous (IV) Ibuprofen Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2020-2031)

3.8.3 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Intravenous (IV) Ibuprofen Sales by Type (2020-2031)

4.1.1 Global Intravenous (IV) Ibuprofen Sales by Type (2020-2025)

4.1.2 Global Intravenous (IV) Ibuprofen Sales by Type (2026-2031)

4.1.3 Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2020-2031)

4.2 Global Intravenous (IV) Ibuprofen Revenue by Type (2020-2031)

4.2.1 Global Intravenous (IV) Ibuprofen Revenue by Type (2020-2025)

4.2.2 Global Intravenous (IV) Ibuprofen Revenue by Type (2026-2031)

4.2.3 Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2020-2031)

4.3 Global Intravenous (IV) Ibuprofen Price by Type (2020-2031)

5 Segment by Application

5.1 Global Intravenous (IV) Ibuprofen Sales by Application (2020-2031)

5.1.1 Global Intravenous (IV) Ibuprofen Sales by Application (2020-2025)

5.1.2 Global Intravenous (IV) Ibuprofen Sales by Application (2026-2031)

5.1.3 Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2020-2031)

5.2 Global Intravenous (IV) Ibuprofen Revenue by Application (2020-2031)

5.2.1 Global Intravenous (IV) Ibuprofen Revenue by Application (2020-2025)

5.2.2 Global Intravenous (IV) Ibuprofen Revenue by Application (2026-2031)

5.2.3 Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2020-2031)

5.3 Global Intravenous (IV) Ibuprofen Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Cumberland Pharmaceuticals

6.1.1 Cumberland Pharmaceuticals Company Information

6.1.2 Cumberland Pharmaceuticals Description and Business Overview

6.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product Portfolio

6.1.5 Cumberland Pharmaceuticals Recent Developments/Updates

6.2 Alveda Pharmaceuticals

6.2.1 Alveda Pharmaceuticals Company Information

6.2.2 Alveda Pharmaceuticals Description and Business Overview

6.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product Portfolio

6.2.5 Alveda Pharmaceuticals Recent Developments/Updates

6.3 CSL Limited

6.3.1 CSL Limited Company Information

6.3.2 CSL Limited Description and Business Overview

6.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.3.4 CSL Limited Intravenous (IV) Ibuprofen Product Portfolio

6.3.5 CSL Limited Recent Developments/Updates

6.4 Sandor Medicaids

6.4.1 Sandor Medicaids Company Information

6.4.2 Sandor Medicaids Description and Business Overview

6.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Product Portfolio

6.4.5 Sandor Medicaids Recent Developments/Updates

6.5 PT. Soho Industri Pharmasi

6.5.1 PT. Soho Industri Pharmasi Company Information

6.5.2 PT. Soho Industri Pharmasi Description and Business Overview

6.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product Portfolio

6.5.5 PT. Soho Industri Pharmasi Recent Developments/Updates

6.6 Germin MED

6.6.1 Germin MED Company Information

6.6.2 Germin MED Description and Business Overview

6.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Germin MED Intravenous (IV) Ibuprofen Product Portfolio

6.6.5 Germin MED Recent Developments/Updates

6.7 Grifols

6.7.1 Grifols Company Information

6.7.2 Grifols Description and Business Overview

6.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Grifols Intravenous (IV) Ibuprofen Product Portfolio

6.7.5 Grifols Recent Developments/Updates

6.8 Gloria Pharmaceuticals

6.8.1 Gloria Pharmaceuticals Company Information

6.8.2 Gloria Pharmaceuticals Description and Business Overview

6.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product Portfolio

6.8.5 Gloria Pharmaceuticals Recent Developments/Updates

6.9 Al Nabeel International

6.9.1 Al Nabeel International Company Information

6.9.2 Al Nabeel International Description and Business Overview

6.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Product Portfolio

6.9.5 Al Nabeel International Recent Developments/Updates

6.10 Laboratorios Valmorca

6.10.1 Laboratorios Valmorca Company Information

6.10.2 Laboratorios Valmorca Description and Business Overview

6.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Product Portfolio

6.10.5 Laboratorios Valmorca Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Intravenous (IV) Ibuprofen Industry Chain Analysis

7.2 Intravenous (IV) Ibuprofen Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Intravenous (IV) Ibuprofen Production Mode & Process Analysis

7.4 Intravenous (IV) Ibuprofen Sales and Marketing

7.4.1 Intravenous (IV) Ibuprofen Sales Channels

7.4.2 Intravenous (IV) Ibuprofen Distributors

7.5 Intravenous (IV) Ibuprofen Customer Analysis

8 Intravenous (IV) Ibuprofen Market Dynamics

8.1 Intravenous (IV) Ibuprofen Industry Trends

8.2 Intravenous (IV) Ibuprofen Market Drivers

8.3 Intravenous (IV) Ibuprofen Market Challenges

8.4 Intravenous (IV) Ibuprofen Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Cumberland Pharmaceuticals

Alveda Pharmaceuticals

CSL Limited

Sandor Medicaids

PT. Soho Industri Pharmasi

Germin MED

Grifols S A

Gloria Pharmaceuticals

Al Nabeel International

Laboratorios Valmorca

List of Tables

Table 1. Global Intravenous (IV) Ibuprofen Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Intravenous (IV) Ibuprofen Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Intravenous (IV) Ibuprofen Market Competitive Situation by Manufacturers in 2024

Table 4. Global Intravenous (IV) Ibuprofen Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Intravenous (IV) Ibuprofen Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Intravenous (IV) Ibuprofen Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Intravenous (IV) Ibuprofen Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Intravenous (IV) Ibuprofen Average Price (USD/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Intravenous (IV) Ibuprofen, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Intravenous (IV) Ibuprofen, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Intravenous (IV) Ibuprofen, Product Type & Application

Table 12. Global Key Manufacturers of Intravenous (IV) Ibuprofen, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Intravenous (IV) Ibuprofen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Ibuprofen as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Intravenous (IV) Ibuprofen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Intravenous (IV) Ibuprofen Sales by Region (2020-2025) & (MT)

Table 18. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2020-2025)

Table 19. Global Intravenous (IV) Ibuprofen Sales by Region (2026-2031) & (MT)

Table 20. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2026-2031)

Table 21. Global Intravenous (IV) Ibuprofen Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2020-2025)

Table 23. Global Intravenous (IV) Ibuprofen Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2026-2031)

Table 25. North America Intravenous (IV) Ibuprofen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Intravenous (IV) Ibuprofen Sales by Country (2020-2025) & (MT)

Table 27. North America Intravenous (IV) Ibuprofen Sales by Country (2026-2031) & (MT)

Table 28. North America Intravenous (IV) Ibuprofen Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Intravenous (IV) Ibuprofen Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Intravenous (IV) Ibuprofen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Intravenous (IV) Ibuprofen Sales by Country (2020-2025) & (MT)

Table 32. Europe Intravenous (IV) Ibuprofen Sales by Country (2026-2031) & (MT)

Table 33. Europe Intravenous (IV) Ibuprofen Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Intravenous (IV) Ibuprofen Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Intravenous (IV) Ibuprofen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Intravenous (IV) Ibuprofen Sales by Country (2020-2025) & (MT)

Table 42. Latin America Intravenous (IV) Ibuprofen Sales by Country (2026-2031) & (MT)

Table 43. Latin America Intravenous (IV) Ibuprofen Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Intravenous (IV) Ibuprofen Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Intravenous (IV) Ibuprofen Sales (MT) by Type (2020-2025)

Table 51. Global Intravenous (IV) Ibuprofen Sales (MT) by Type (2026-2031)

Table 52. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2020-2025)

Table 53. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2026-2031)

Table 54. Global Intravenous (IV) Ibuprofen Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Intravenous (IV) Ibuprofen Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2020-2025)

Table 57. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2026-2031)

Table 58. Global Intravenous (IV) Ibuprofen Price (USD/Kg) by Type (2020-2025)

Table 59. Global Intravenous (IV) Ibuprofen Price (USD/Kg) by Type (2026-2031)

Table 60. Global Intravenous (IV) Ibuprofen Sales (MT) by Application (2020-2025)

Table 61. Global Intravenous (IV) Ibuprofen Sales (MT) by Application (2026-2031)

Table 62. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2020-2025)

Table 63. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2026-2031)

Table 64. Global Intravenous (IV) Ibuprofen Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Intravenous (IV) Ibuprofen Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2020-2025)

Table 67. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2026-2031)

Table 68. Global Intravenous (IV) Ibuprofen Price (USD/Kg) by Application (2020-2025)

Table 69. Global Intravenous (IV) Ibuprofen Price (USD/Kg) by Application (2026-2031)

Table 70. Cumberland Pharmaceuticals Company Information

Table 71. Cumberland Pharmaceuticals Description and Business Overview

Table 72. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 73. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product

Table 74. Cumberland Pharmaceuticals Recent Developments/Updates

Table 75. Alveda Pharmaceuticals Company Information

Table 76. Alveda Pharmaceuticals Description and Business Overview

Table 77. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 78. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product

Table 79. Alveda Pharmaceuticals Recent Developments/Updates

Table 80. CSL Limited Company Information

Table 81. CSL Limited Description and Business Overview

Table 82. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 83. CSL Limited Intravenous (IV) Ibuprofen Product

Table 84. CSL Limited Recent Developments/Updates

Table 85. Sandor Medicaids Company Information

Table 86. Sandor Medicaids Description and Business Overview

Table 87. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 88. Sandor Medicaids Intravenous (IV) Ibuprofen Product

Table 89. Sandor Medicaids Recent Developments/Updates

Table 90. PT. Soho Industri Pharmasi Company Information

Table 91. PT. Soho Industri Pharmasi Description and Business Overview

Table 92. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product

Table 94. PT. Soho Industri Pharmasi Recent Developments/Updates

Table 95. Germin MED Company Information

Table 96. Germin MED Description and Business Overview

Table 97. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 98. Germin MED Intravenous (IV) Ibuprofen Product

Table 99. Germin MED Recent Developments/Updates

Table 100. Grifols Company Information

Table 101. Grifols Description and Business Overview

Table 102. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 103. Grifols Intravenous (IV) Ibuprofen Product

Table 104. Grifols Recent Developments/Updates

Table 105. Gloria Pharmaceuticals Company Information

Table 106. Gloria Pharmaceuticals Description and Business Overview

Table 107. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 108. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product

Table 109. Gloria Pharmaceuticals Recent Developments/Updates

Table 110. Al Nabeel International Company Information

Table 111. Al Nabeel International Description and Business Overview

Table 112. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 113. Al Nabeel International Intravenous (IV) Ibuprofen Product

Table 114. Al Nabeel International Recent Developments/Updates

Table 115. Laboratorios Valmorca Company Information

Table 116. Laboratorios Valmorca Description and Business Overview

Table 117. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 118. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product

Table 119. Laboratorios Valmorca Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Intravenous (IV) Ibuprofen Distributors List

Table 123. Intravenous (IV) Ibuprofen Customers List

Table 124. Intravenous (IV) Ibuprofen Market Trends

Table 125. Intravenous (IV) Ibuprofen Market Drivers

Table 126. Intravenous (IV) Ibuprofen Market Challenges

Table 127. Intravenous (IV) Ibuprofen Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Intravenous (IV) Ibuprofen

Figure 2. Global Intravenous (IV) Ibuprofen Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intravenous (IV) Ibuprofen Market Share by Type: 2024 & 2031

Figure 4. 100 mg Dose Product Picture

Figure 5. 200 mg Dose Product Picture

Figure 6. 400 mg Dose Product Picture

Figure 7. 800 mg Dose Product Picture

Figure 8. Global Intravenous (IV) Ibuprofen Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Intravenous (IV) Ibuprofen Market Share by Application: 2024 & 2031

Figure 10. Pain

Figure 11. Fever

Figure 12. Inflammation

Figure 13. Global Intravenous (IV) Ibuprofen Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Intravenous (IV) Ibuprofen Market Size (2020-2031) & (US$ Million)

Figure 15. Global Intravenous (IV) Ibuprofen Sales (2020-2031) & (MT)

Figure 16. Global Intravenous (IV) Ibuprofen Average Price (USD/Kg) & (2020-2031)

Figure 17. Intravenous (IV) Ibuprofen Report Years Considered

Figure 18. Intravenous (IV) Ibuprofen Sales Share by Manufacturers in 2024

Figure 19. Global Intravenous (IV) Ibuprofen Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Intravenous (IV) Ibuprofen Players: Market Share by Revenue in Intravenous (IV) Ibuprofen in 2024

Figure 21. Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Intravenous (IV) Ibuprofen Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Intravenous (IV) Ibuprofen Sales Market Share by Country (2020-2031)

Figure 24. North America Intravenous (IV) Ibuprofen Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country (2020-2031)

Figure 28. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country (2020-2031)

Figure 29. Germany Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Region (2020-2031)

Figure 36. China Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Country (2020-2031)

Figure 47. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Intravenous (IV) Ibuprofen Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Intravenous (IV) Ibuprofen by Type (2020-2031)

Figure 57. Global Revenue Market Share of Intravenous (IV) Ibuprofen by Type (2020-2031)

Figure 58. Global Intravenous (IV) Ibuprofen Price (USD/Kg) by Type (2020-2031)

Figure 59. Global Sales Market Share of Intravenous (IV) Ibuprofen by Application (2020-2031)

Figure 60. Global Revenue Market Share of Intravenous (IV) Ibuprofen by Application (2020-2031)

Figure 61. Global Intravenous (IV) Ibuprofen Price (USD/Kg) by Application (2020-2031)

Figure 62. Intravenous (IV) Ibuprofen Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Ibuprofen Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions